1,0
30. März 2022
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Trying to solve complex issues in healthcare.
Kontras
Over spending investor funding on development without any strategic product direction or leadership. No accountability for new execs. Lack of focus on client needs and over engineered design based on a "vision" without client input. Operating as to separate entities due to relationship with investor partner has completely derailed any initial progress.